Sun Pharmaceutical Industries Limited has received a confirmation certificate related to dematerialization requests for the quarter ended December 31, 2025. The certificate, dated January 5, 2026, was received from MUFG Intime India Pvt. Ltd., the Registrar & Share Transfer Agent. This confirms compliance with regulatory requirements regarding securities dematerialization.
Certificate of Confirmation
Sun Pharmaceutical Industries Limited has announced the receipt of a confirmation certificate from M/s. MUFG Intime India Pvt. Ltd., concerning the dematerialization of securities. This certificate covers the fiscal quarter ending December 31, 2025, and is dated January 5, 2026.
Details of Compliance
The confirmation pertains to Regulation 74(5) of the relevant regulations, and verifies that securities received for dematerialization during Q3 (Oct-Dec) 2025 were duly processed. MUFG Intime India Pvt. Ltd. confirmed that the certificates have been listed on applicable stock exchanges.
Handling of Security Certificates
The Registrar and Share Transfer Agent verified that security certificates received for dematerialization were properly handled. The certificates were confirmed, and appropriately mutilated and cancelled after verification. Additionally, the register of members was updated to reflect the change in ownership.
Source: BSE
